Abstract:Diabetes mellitus (DM) is a long term disorder of metabolism characterized by high level of blood sugar (hyperglycemia) due to insufficient secretion of insulin, insulin resistance, or both, as well as poor lipid, protein and carbohydrate metabolism. These complications occur as a result of derangement in glucose storage for the regulatory system and metabolic fuel mobilization, including carbohydrate, protein and lipid anabolism and catabolism emanating from impaired action of insulin, secretion of insulin, or both. The in silico study was conducted with the help of molecular docking to treat diabetes to inhibit the activities of α-amylase and α-glucosidase by drug molecule. All the studies were based on docking with molecules. The docking was done using a docking software between all the ligands and the target protein receptors. Natural compounds, such as Conduritol A, Catechin and Quercetin were picked, and protein targets as α-amylase and α-glucosidase. Ligands were imported for visual screening into PyRx software while Biovia Discovery Studio Visualizer was used for protein preparation. Analysis of the properties of drug likeliness of the ligands was done via SwissADME online server according to Lipinski’s Rule of Five. Final docking analysis was done through AutoDockVina and Biovia Discovery Studio client 2020. Molecular docking analysis of the ligands Conduritol A, Catechin and Quercetin showed strong binding interaction with both α-amylase and α-glucosidase. The test revealed different binding affinities, hydrogen bond interactions, hydrophobicity, solvent accessibility surface (SAS), root mean square deviation lower bound (RMSD LB) and root mean square deviation upper bound (RMSD UB). Conduritol A was the strongest compound against the protein targets, with its low binding strength, according to the PyRx test and Lipinski 's Rule of Five. The same molecules were further docked, and the interactions were visualized under PyMol Via Biovia Discovery Studio. According to the in silico study, we have found that these natural compounds can inhibit the activities of α-amylase and α-glucosidase which can be promising drugs for the treatment of diabetes after subjecting them to in vitro and in vivo studies.

Molecular docking study on interaction mode between yeast AHAS and sulfonylureas inhibitors

Molecular docking and molecular dynamic simulations of inhibitor ZJ0777 and CIE binding to acetohydroxyacid synthases

Molecular design, synthesis and biological activity evaluation of novel AHAS inhibitors based on receptor structure

Interaction and CoMFA studies on A-thaliana acetohydroxyacid synthase by sulfonylureas

Synthesis, Crystal Structure And Biological Activity Of N-(4-Methyl-Pyrimidin-2-Yl)-N '-2-(Nitrophenylsulfonyl)Urea And Its Docking With Yeast Ahas

Design, Synthesis and SAR Study of Novel Sulfonylurea Derivatives Containing Arylpyrimidine Moieties As Potential Anti-Phytopathogenic Fungal Agents

Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.

Structure-activity Relationships for a New Family of Sulfonylurea Herbicides

Study on the Bioactivity Changes of Hydroxylated Sulfonylureas Derivatives: A Possible Metabolism

3D-QSAR Studies of 2,4-Thiazolidinediones As Aldose Reductase Inhibitors Using CoMFA,CoMSIA and Molecular Docking

Insight into the Interaction Mechanism of Human SGLT2 with Its Inhibitors: 3D-QSAR Studies, Homology Modeling, and Molecular Docking and Molecular Dynamics Simulations

Design, Synthesis and Biological Activity of Substituted-N-[4-（substituted-phenylsulfamoyl）phenyl]benzamide As Potential AHAS Inhibitors

Homology Modeling and Molecular Docking of Xylitol Dehydrogenase from Aspergillus Oryzae

Structure Based Docking of Secondary Metabolites against Alpha-amylase and Alpha-glucosidase Activities in Treating Diabetes

Structure-based molecular docking and molecular dynamics simulations study for the identification of dipeptidyl peptidase 4 inhibitors in type 2 diabetes.

Quinoline-based Schiff bases as possible antidiabetic agents: ligand-based pharmacophore modeling, 3D QSAR, docking, and molecular dynamics simulations study

Structural Characterization of Plasmodial Aminopeptidase: a Combined Molecular Docking and QSAR-based in Silico Approaches

Design of Novel Thiazole‐based Schiff Analogs as α‐Amylase Inhibitors Using 3D‐QSAR, ADME‐Tox, Molecular Docking, Molecular Dynamics, Biological Efficacy, and Retrosynthesis

Design, synthesis, herbicidal activity, in vivo enzyme activity evaluation and molecular docking study of acylthiourea derivatives as novel acetohydroxyacid synthase inhibitor

Parsing structural fragments of thiazolidin-4-one based α-amylase inhibitors: A combined approach employing in vitro colorimetric screening and GA-MLR based QSAR modelling supported by molecular docking, molecular dynamics simulation and ADMET studies

Synthesis and Biological Activities of Some Novel N-Aryl Sulfonyl Trytophanates and N-Aryl Sulfonyl Glutamates